This expert commentary by Barry Halliwell analyzes and contextualizes the findings from Ghanem et al., who reported that high-dose ascorbate (vitamin C) selectively induces death in breast cancer cells through redox imbalance and metabolic disruption. The mechanism involves increased oxidative stress, mitochondrial dysfunction, ATP depletion, and a shift in cellular